May 4, 2017 / 8:19 PM / 4 months ago

BRIEF-Biomarin Q1 GAAP loss per share $0.09

May 4 (Reuters) - Biomarin Pharmaceutical Inc:

* Biomarin announces first quarter 2017 financial results

* Q1 GAAP loss per share $0.09

* Q1 earnings per share view $-0.29 -- Thomson Reuters I/B/E/S

* Q1 revenue $304 million versus I/B/E/S view $288.9 million

* Biomarin Pharmaceutical- as of march 31, 2017, had cash, cash equivalents and investments totaling $1.2 billion, versus $1.4 billion on december 31, 2016

* Biomarin pharmaceutical inc - 2017 financial guidance is unchanged Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below